Regulatory Updates
🇺🇸 FDA Page 24FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 277–288 of 373 articles
RFK Jr.’s Muddled Claims on Drug Approval Speed in Oncology
oncology · 3 min
Dr. Sarah MitchellFive Key Regulatory Updates to Watch at ASCO
FDA · 4 min
Dr. Sarah MitchellFDA Fast Track Designation for Oncology Drugs: April 2026 Insights
FDA · oncology · 3 min
Dr. Sarah MitchellFDA in Flux: May 2026 Drug Approvals Update
FDA · 2 min
Dr. Sarah MitchellBest Cancer Stocks for 2026: Investment Insights
oncology · 3 min
Dr. Sarah MitchellFirst RAS Inhibitor Extends Survival in Metastatic Pancreatic Cancer
FDA · metastatic pancreatic adenocarcinoma · 3 min
Dr. Sarah MitchellFDA's Guidance on Animal Testing Alternatives: Industry Concerns
FDA · 2 min
Dr. Sarah MitchellAptar Pharma Advances FDA-Funded Research Contract for Drug Approvals
FDA · 2 min
Dr. Sarah MitchellBioMarin Seeks Approval for Voxzogo in Short Stature Indication
short stature · 3 min
Dr. Sarah MitchellAtara Bounces Back with FDA Approval in Oncology
FDA · oncology · 4 min
Dr. Sarah MitchellBioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech
rare disease · 2 min
Dr. Sarah MitchellNew FDA Guidance on ENDS and Nicotine Pouch Products
FDA · 2 min
Dr. Sarah MitchellExplore intelligence